The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech
Stock and Other Ownership Interests - Genentech
MyTACTIC: Activity of targeted therapy in patients (pts) with advanced solid tumors harboring specific biomarkers.
 
Lee S. Schwartzberg
Consulting or Advisory Role - Abbvie; AstraZeneca; BeyondSpring Pharmaceuticals; BMSi; Coherus Biosciences; Daiichi Sankyo; Epic Sciences; Foundation Medicine; Genentech; GlaxoSmithKline; Helsinn Therapeutics; Lilly; Mirati Therapeutics; Myriad Genetics; Napo Pharmaceuticals; Novartis; Pfizer; Sandoz; Sanofi; Seagen; Spectrum Pharmaceuticals
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Merck; Pfizer; Seagen
 
David R. Spigel
Leadership - ASCO (Inst)
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); Jazz Pharmaceuticals (Inst); Lyell Immunopharma (Inst); MedImmune (Inst); Monte Rosa Therapeutics (Inst); Novartis (Inst); Novocure (Inst); Sanofi/Aventis (Inst)
Research Funding - Abbvie (Inst); Aeglea Biotherapeutics (Inst); Agios (Inst); Amgen (Inst); Anheart Therapeutics (Inst); Apollomics (Inst); Arcus Biosciences (Inst); Arrys Therapeutics (Inst); Ascendis Pharma (Inst); Asher Biotherapeutics (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); BioNTech (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Celldex (Inst); cyteir (Inst); Daiichi Sankyo (Inst); Denovo Biopharma (Inst); Eisai (Inst); Elevation Oncology (Inst); Ellipses Pharma (Inst); EMD Serono (Inst); Endeavor BioMedicines (Inst); Erasca, Inc (Inst); Evelo Biosciences (Inst); Faeth Therapeutics (Inst); Foundation Bio (Inst); Fujifilm (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); GRAIL (Inst); Hutchison MediPharma (Inst); ImClone Systems (Inst); Immunogen (Inst); Incyte (Inst); Ipsen (Inst); Janssen Oncology (Inst); Janux Therapeutics (Inst); Jazz Pharmaceuticals (Inst); Kronos Bio (Inst); Lilly (Inst); Loxo (Inst); Lyell Immunopharma (Inst); Macrogenics (Inst); MedImmune (Inst); Merck (Inst); Millennium (Inst); Moderna Therapeutics (Inst); Monte Rosa Therapeutics (Inst); Nektar (Inst); Neon Therapeutics (Inst); Novartis (Inst); Novocure (Inst); Oncologie (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Phanes Therapeutics (Inst); PTC Therapeutics (Inst); PureTech (Inst); Razor Genomics (Inst); Repare Therapeutics (Inst); Rgenix (Inst); Seagen (Inst); Shenzhen Chipscreen Biosciences (Inst); Stemline Therapeutics (Inst); Strata Oncology (Inst); Synthekine (Inst); Taiho Oncology (Inst); Takeda (Inst); Tango Therapeutics (Inst); Tarveda Therapeutics (Inst); Tesaro (Inst); Tizona Therapeutics, Inc. (Inst); Transgene (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst); Verastem (Inst); Zai Lab (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genentech; Novartis
 
Ari VanderWalde
Employment - Caris Life Sciences
Consulting or Advisory Role - West Cancer Center, George Clinica
 
Richard Michael Zuniga
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Mirati Therapeutics
 
Jason Hong
Employment - Genentech
 
Tania Szado
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche; Moderna Therapeutics; VIR Biotechnology
 
Bongin Yoo
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Luke Passler
No Relationships to Disclose
 
Yong Wang
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Walter C. Darbonne
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
 
Davey Daniel
Employment - OneOncology/ Tennessee Oncology; OneOncology/ Tennessee Oncology (I)
Leadership - OneOncology
Speakers' Bureau - Ideology Health; Ideology Health (I)
Research Funding - Genentech, Guardant, Janssen, BMS G1 Therapeutics Merck, Novartis, Abbvie, ARMO Biosciences Lilly Merus, Daiichi, Roche, Celgene, Roche, EQRX, AstraZeneca